Publication
Article
Pharmaceutical Technology
Pharmaceutical Technology-07-02-2003Volume27 Issue 7
Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance
Pharmaceutical companies must take a holistic look at their systems and supporting processes to implement FDA's risk-based approach into their 21 CFR Part 11 complaince strategies.
Articles in this issue
July 2003
Gastrorentention: A Means to Address Regional Variability in Intestinal Drug Absorption
The Push for Generics Challenges Manufacturers
Emerging Research Opportunities in Oral Inhalation Technology
Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance
Preventing Metal Contamination
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
